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Backgrollnd. Leukocyte migrfllioll imo tlie ischemic area is a complex process, COIl/rolled
byadheJioll molecules (AM) ;11 leukocytes C1nd endothelium, by migratory capacity ofleu-
kocytes and the presence ojhemotaxic ClgetHS in the fissue. In 111is research it lVas supposed
that ill the blood and cerebrospinalfluid (CSF) ofpatieflls ill the GClIle phase ojischemic
brain disease (/DD) there were relevalll changes ;11 the COI/Cellifatioll ofsoluble AM (51-
CAM-), sVCAM·} and sE·selectin), that could Jlm'e been the itulictllors ojthe imellsity oj
damaging processes ill cemraillervolls system (CNS). Methods, The study illdllded 45 180
patiellls, 15 witli trallsient ischemic auack (TlA), /5 witli reversible ischemic arrack (RIA),
wuJ 15 with brain i,ljarction (81), ojborJl sexes, mea" age 66±7, Comrol group cOl/sisred of
15 patients with radicular lesions ofdiscal origin, subjected 10 diagnostic radiculography,
without the signs ofinterruptioll ill tht! passage ofCSF. Challges ofselected biochemical
parameters were determined ill all patiellts illJrame 72 hours shlee the occ:urellce ojau is-
chemic episode. Conee1l1rations of soluble AM were determined ill plasma and CSF by
ELISA. Toral Illlmber ojleukocytes (TNL) in peripheral blood was determined by hemato-
logical analyzer. Res"lls. The results sllOlI'ed tlwt dllring theftrst 72 Jlrs ofIBD significant
i"cremes occured ill TNL and that the increase was progressive compared to tile severe-
ness ojthe disease. Signijic(ul1 increase ojsoluble AM eOflcell1ratioll was shown ill plasma
ofIBD paziems. The increase Wa.I highest in 81, samen-hal/ower in RIA and the (owesl ill TJA
patiems compared 10 rile control. III CSF concentrations of sleAM-I, sVCAM-1 and sE-
se/eeIiI/ denuJIlstmred similar increasi"g tre"d as in plasma. COllclusio". TNL as well as rile
soluble AM collcemrOliolls ill plasma and eSF, were inrreased during lile (lcute IJ3D phase
and progressil'l' ill relarion to the severcness ofthe disease, so that they might IUlI'c bee" the
indicators ofeNS inflammatory refletioll imensity. Furthermore, the results indicated tlleir
rote i/l 180 par/wgellesis alJ(l offered Ille possibility ofresearclling flie applicarjoll ofantago-
nists (lIuVor (lctivit)' modulatorsofsome ojthem in IBD therapy.
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Introduction
Most recent studies indicme the existence and t:1C de-
velopmenl of inflammJtory reaclion during ischemic brain
discase (180). Two bJsic processes .Ire responsible for the
development of inOammatory reaction in eNS during
ischemia: local reaction of brain cells and leukocyte migra-
tion from circulation into the ischemic parenchyma (1-7).
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Local reaction of brain cells occurs during a few minutes
(neurons and microglia), or hours (astrocytcs) after ische-
mia. At the neuron level the cClllral event is the increase of
intracellular concentration of Ca
2
+. uncontrolled release of
neurotransmilters. increased production of free radicals.
lipid mediators. derivatives of arachidonic acid, acidosis,
etc. The process ofexilotoxicity leads to cellular death, and
to the damages of the surrounding neurons, glial and endo-
thelial cells (8-12). Furthermore. microglia activated with
ischemia and astrocylcs by lhe secretion of large amounlS of
citotoxic mediators playa significant role in additional neu-
ronal and endothelial cell damage as well as in the devel-
opmcnt of the second phase of inflammatory reaction
(12-14). Pharmacological modulation of microglia effects
might contribute (Q thc improvement of structural and fune-
tionaIoutcome of brain ischemia.
The second phase of inflammatory reaction develop-
ment includes infiltration of peripheral inflammatory cells
(neutrophils, monocytes and lymphocytes) in ischemic pa-
renchyma. Leukocyte migralion into the ischemic area is a
complex process. controlled by adhesion molecules in leu-
kocytes and endothclium, by migratory c3pacity of leuko-
cytes and the presence of hemotaxic agents in the tissue (3.
15-18). Human data are scarce: a high number of radio-
labeled polymorphonuclear leukocyles that occur in slightly
perfused brain areas 6 to 12 hours after the ictus. and au-
topsy show intense leukocyte infiltration of brain paren-
chyma 2 10 3 days aflcr Ihe stroke (I. 3). Experimental stud-
ies suggest that the carly occurence of leukocytes in 10 the
brain parenchyma is independent from the presence of ne-
crosis, which leads to the hypothesis that these cells havc a
role in the progression from ischemia to brain infarction (3.
15).
The occurence of leukocytes in the ischemic area is a
multistep process (4, 5). They marginate in the venu!es, then
adhere to endothelial cells, and finally migrme into the brain
parenChyma. During each of these steps, their functions are
regulmed by the inflammation-related molecules that are be-
ing produced soon after the onset of cerebral ischemia. The
signuls mediming Ihe entry of leukocytes into the ischemic
area have not yet been completely unfolded, but a number of
clues suggest thal cytokines playa significant role in this
process. Cytokincs may have various functions during cere-
bral ischemia: they can attract leukocytes and stimulate syn-
thesis of the adhesion molecules in leukocytes, endothelial
cells. and other cells. thus promoting the inflammatory re-
sponse of the damaged cerebr.1 lissue (3. 5, 7. 18).
Migration of peripheral blood lcukocytes requires
prior adhesion to cerebral endothelial cells, which is medi-
ated by thc adhesion molecules on Ihe surface of cerebral
endotheli.l cells and peripheral blood leukocytes (3. 4. 16).
In cerebral ischemia at least 3 different adhesion molecules
have merited special interest so far: intercellular adhesion
molecule I (ICAM-I), responsible for the adhesion of
mononuclear cells and granulocytes. vascular cell adhesion
molecule 1 (VCAM-l) which predominantly mcdiatcs ad-
hesion of mOtlocytes. and endothelial leukocyle adhesion
molecule (E-selectin), expressed only by cndothelial cells
and facilitates adhesion of monocyte!) and granulocytcs (3.
4.7. 16-22).
In physiologic conditions. adhesion molecules are
scarcely expressed 011 cell surface. but their expression
might be induced by diverse palhophysiological processes
(3. 4. 18-22). Circul.ting. soluble forms of the molecules
are formed in the proteolytic release of their extracellular
domains (16-18). Raised levels of soluble adhesion mole-
cules have beer. described in various inflammatory and ma-
lignant diseases or infeclions, and it has been suggested that
they were markers ofdise.ses .clivity (4. 16. 18.20.22).
The exact pathogenic role of the mentioned adhesion
molecules during brain ischemia in human has still not been
completely defincd. Previous studies do not offer data
whether the expression of these adhesion molecules and
concentration of their soluble forms is related to clinical
disorders and recovering of the patients with IBD. Besidcs,
there are no data on the dynamics of the adhesion molecules
expression in patients with the different types of IBO. The
question of differences between soluble adhesion molecule
level in plasma and CSF in patients during the initial phase
of IBO remains to be clarified. Responses to the opened
questions could be significantly involved intO the funher
therapy strategy of ISD directed at inflammatory reaction.
but could also be important for clinical practice in determin-
ing the severeness of the disease and the recovery during
the IDD initial phase.
In this research it was supposed that there were rele·
vant changes in the concentration of soluble adhesion mole-
cules (sICAM-1. sVCAM-1 and sE-seleclin) in Ihe blood
and cerebrospinal fluid of patients in the acute phase of
IBO. Those changes were the indicators of the intcnsity of
damaging processes in eNS. The concentration of soluble
adhesion molecules in plasma and cerebrospinal fluid. as
well as the tot.1 number of leukocytes io peripheral blood
was monitored in IBD patienls in framc 72 hours since the
formation of an ischemic episode.
Methods
Study included 45 IBO palients of both sexes. mean
age 66±7. The diagnosis W;IS established by medical his-
tory, clinical examination. and cerebral CT scans. After in-
stitutional approval. informed consent was obtained from all
patients before study entry. Fifteen patients had transient is-
chemic attack (TIA). defined as complete recovery from
clinical symplOms within 24 hours. fifteen paticnls had re-
versible ischemic allack (RIA), defined as complete recov-
ery from neurological deficits within 7 days, and fifteen pa-
tients had brain infarction (81), defined as neurological
deficits persisting for more then 7 days. Exclusion criteria
for the patients were the presence of infections. other cere-
bral, inflammatory, pulmonary, hepatic, renal and malignant
diseases. or immunosuppressive Ireatment.Gpoj 2 BOJHOCAHMTETCKM nPErJlE.1\ Crpalla 141
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fig. 2 - Concentration ofsICAM-l. sYCAM-I and sE-selcctin
in plasma of patients with br<lin infarction (BI), rcvcr~iblc
ischemic attack (RIA). and transient ischemic attack (TIA) dur-
ing the first 72 hours after insults. Values ;:Ife givcn as meant
SD. "'(p<0.05), "(p<O.OI). "'''(1'<0.001)- signific:mcc 10 cor-
responding control values.
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Fig. J - Touli number ofleukocytes (x 10
9/1) in peripheral
blood ofpatienLs with brain infarction (81), reversible ischemic
auack (RIA), and transient ischemic attack (TIA) during lhe
first 72 hours after insults. Values arc given as lllcan±SD.
*(p<0.05), "(1'<0.01). ***(p<O.OO 1)- ;ignificance to corre-
sponding control values,
693.84 ± 91.12 ngiml for sfCAM-I. (p<O.ool); for
sVCAM-I was 687.24 ± 156.96 ngim!. (p<O.ool); and for
sE-seleClin was 51.13 ± 17.57 ng/ml. (p<O.ool compared to
Ihe conllol). (Figure 2).
The results showed that during the first 72 hours of
ISO the significant increase in leukocytc number in periph-
eral blood occured being progressivc according to the
severeness of lhe disease. In 81 patients valucs were 9.29 ±
1.89 x10'/1 . (1'<0.00I compared to the conllol). (Figure I).
The results showed significJI1l increase of sICAM-I,
sVCAM~l and sE·selectin conccntration in plasma of ISO
patients, while the increase W;,l~ the highest in 81 patients,
somewhat lower in RIA patients. and the lowest in TIA pa-
tients. Plasma concentration of sAM in 81 patients was
Resulls
In all IBO patients the level of soluble adhesion mole-
cules. as well as the lOlaI number of leukocytes was deter-
mined within the 72 hours since the occurence of ischemic
episode.
COOirol group consisled of 15 palients of adequate age
and gender. with radicular lesions of discal origin (Ium·
basacral area). subjecled 10 diagnostic radiculography.
without the imcrruptlon signs in the passage of cerebrospi-
nal Ouid. Only Ihe patienLs with the abrupt development of
motor deficit without pain and thus without 3nalgesic Iher-
apy "ere included in lhe study. and cytochemical and im-
munochemical findings in CSF wcre within physiological
limits. Patients with intensive radicular pains who used non-
steroidal analgesics. as well as patients with anamnesis and
clinical data on current inflammatory, neurodegeneralive
and psychiatric diseascs were excluded from the study.
In all Ihe teMed patients blood and CSF samples were
taken in the period of 810 10 AM. before any Iherapy was
given. Peripheral vein blood samples (3 ml) were collected
ill heparinized glasses at low temperatures. Plasma was se-
lected by Ihe centrifugation of the whole blood during 15
min at 3000 rpm, at +4°C.
CSF samples (I 1111) were laken during (he lumbar
puncture illlo the glasses held on ice (+4°C). Plasma and
CSF samples were kept 31 _70°C until the biochemical
:mulyses. The un:Jly~cs were performed within 6 month ancr
the samples colection.
Concenlr:llions ofsoluble adhesion molecules sICAM-
I, sVCAM-1 and sE-seleclin were determined in pla~ma
and CSF by ELISA (R&D Systems Europe. Abingdon.
UK). Plnsma samples were diluted with commercial dilu-
ents for detecling sICAM-I in ratio 1:80, for s-VCAM-I
and ~E-sclectin in ratio I:50, and all samples ofCSF in r:Hio
I:l. Total numbers of leukocytes in peripheral blood were
determined by hematological analyzer Technicon H- I. All
samples were analyzed in duplicate, and the mean value was
calculated. lnlraessay and interessay precision (coefficient
of variatIon) for all of Ihese assay were <5.9% and <10.2%.
respectively.
The valucs of the monitored parameters were repre-
scnted as mean ± standard deviation. Statistical significance
of the differences between ISO and the control values was
assessed by Studelll's Hest (with p<O.05 as significant).CTjlalla 142 BOJHOCAHI1TETCKI1 nPErJlE.ll 6poj 2
ness and its duration. The efforts of contemporary aCUle
ISO therapy are directed towards brain tissue protection be-
fore the development of irreversible damage occurs. Nu-
merous studies showed lhat reversible ischemic stadium
gradually progressed towards infarction. CCnlral zone, with
highly compromised blood flow is surrounded by the zone
wilh milder ischemic level (penumbra), where electrical ac-
tivity is damaged, but cell metabolism and neuron viability
are partially preserved, making Ihe final outcome in this
zonc is variable and dependent on numerous factors that af-
fect time and spatial propagation of damaging and/or de-
fense reaclions after the establishing of lhe reperfusion.
Possible lhcrapy is directed to words the ischemic damage
area because il is likely to cxpect that, due to the partially
present cirCUlation, the remedy reaches the largeled place.
The volume of the infarction area, and consequently the
clinical ISO outcome depend on the outcome of the penum-
bra process (25-30).
During the last few years researches were directed to-
wards the inflammatory reaction in ischemic penumbra
zone. It was demonstrated on the experimental model of
ISD lhat this pathophysiological event was followed with
rhe leukocyte infiltration inro the brain parenchyma and the
brain edema development (IS. 31-34).
Results obtained in this research showed thal in the
acute brain ischemic period the important increase in
number of leukocytes in the peripheral blood occured and
that the increase was highest in patients with brain infarc-
lion. The mechanisms leading to leukocyte migration
through the blood-brain barrier into the central nervous
system, however, remained incompletely established. The
inflammatory process was, thought, to be initiated by lo-
cally produced proinOammatory cytokines such as TNFa,
IL-IP. IL-6 and lFNy (4, 5, 16-18,21). These cytokines
have the capacity to induce or enhance the expression of
several adhesion molecules including ICAM-1. YCAM-I.
and E-selectin at least in the cultured brain vascular endo-
thelium. Furthermore, in viTro stimulation of aSITOcytes
and endothelial cells by prointlammatory cytokines re-
sulted in the expression of chemokines - the low-
moleculor-weight proteins specializ~d 10 recruit specific
subpopulalions of leukocytes [Q the areas of inflammation
(3-5. 35).
There are numerous mechanisms of damaging tt-e is-
chemic parenChyma by leukocytes: they may clog linle
blood vessels and impede complete recuperation of blood
flow in ischemic area after the establishing of reperfusion.
Furthermore. by the release of cylotoxic enzymes, reactive
oxidative species. nitric oxide and products of phospholipid
cascade leukocyles could cause disturbance of brain artery
vasoreactivity and contribute to the blood-brain barrier
damage and the formation of brain postischemic edema.
Also. the induced disorder of endothelial cells and basal
membrane integrity, might faciliw.te erythrocyte exit into
the tissue, as well as hemorrhagic infarct transformation
(/9,33,36-38).
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Fig. 3 - Concentration ofsleAM-I, sVCAM-l and sE-selectin
in CSF ofpar;cnts with brain infarction (BJ), reversible
ischemic attack (RIA), and transient ischemic attack (TtA) dur-
ing the first 72 hours after insults. Values are given as mean±
SD. *(p<O.05). **(p<O.O0,***(p<O'()()1)- significance to cor-
responding control values.
Physiopathologically. ischemia represents a metabolic
disorder in brain functioning caused by the circulation re-
duction thaI ends in morphological damages of neural ele-
ments. Namely, lhe primary stimulus, which triggers a cas-
cade of metabolic changes that end in nerve cell death, is
the energetic crisis or the excessive (uncontrolled) depolari-
zation (12, 23-25). Change from reversible into irreversible
neuron damage depends above all on rhe ische nic severe-
I'
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Discussion
In CSF concentration of sICAM-I, sYCAM-1 and sE-
seleclin demonstrated simil:!r incrcilse trend 3S in plasma.
CSF concentration of sAM in BI patients was 3.24 ± 0.78
nglml, for sICAM-1 (p<O.OOI); for sYCAM-1 was 8.87 ±
2.61 nglml, (p<O.OOI); and for sE-selectin was 0.140 ±
0.045 nglml, (p<0.05 compared to the control), (Figure 3)."poj 2 BOJHOCAHHTETCKH IlPErJlE.l\ Grpalla 143
Endothelial cells aClivmion as the consequence of brain
ischemia, caused adhesion molecules expression, like leAM-
I, VCAM-I and E-selcctin that were released into the circula·
tion during the process of proteolysis. The results ofrecent ill
viJro studies showed that E~seleclin was similarly upregulated
only transiently during the first hours. whereas immunoglobu·
lin-tipe adhesion molecules (lCAM-1 and YCAM-I) were
persistently expressed at cellular surfaces for at least 72 hours
aftcr cytokine stimulation (4, 17, 18,22). This corresponded
with the current concepts of the initial steps of inf1ammation:
selectins were considered ro sustain the phenomenon of mar-
ginalion and the initial light attachment of circulating leuko-
cytes to activated microvascular endothelium. The immu-
noglobulin-type adhesion molecules are particularly important
for the subsequent firm altachment and transendorhelial mi-
gration into the surrounding tissue (17-21). The results of this
research showed significant increase of sICAM-I, sYCAM-I
and sE-selectin concentr:uion in plasma and CSF of palients
with brain infarction in the acute period of the disease. In pa-
tients with RIA and TIA, there waS a signirtcam increase of
sICAM-I and sYCAM-I concentration, but the values were
lower than in the brain infarction. Besides, sE-selectin con-
centralion in pmients with RIA and TIA was relevantly in-
creased in plasma during first 72 hours after the ischemic at-
tack. The obtained results pointed to different dynamics of
changes in sICAM-l, sYCAM-I and sE-selectin concentrn-
tion in plasma and CSF in the acute IBD phase in dependence
011 IBD severeness, proving that there was different level of
innamrnatory reaction intensity during IBD. Brain infarction,
as the severest TBD form with the highest level of morpho-
logical damages of brain parenchyma, has the most pro-
nounced seconda.ry inOammation as its consequence. It was
confimled in this research with the fact that the highest levels
of all tcslcd soluble adhesion molecules in plasma and CSF
were obtained in the Jcute phase in patients with brain infarc-
tion.
The imponance of leukocyte/cerebral endothelial cells
intcractions in regulating inflammatOry responses of ischcmic
brain tissue was supported by following findings: a) the in-
creased leukocytc infihrJtion in the brain during ische-
mia/reperfusion was accompanied by the increased expression
of adhes10n molecules 111 cerebral micro\lessels~ b) depletion
of circulating neutrophils (Le. neutropenia) reduced the in-
farction size and edema in various experimental models of
cerebral ischemia; c) the administration of antibodies against
leukocyte or endothelium expressed adhesion molecules in
experimenlJll animals before and after ischemia decreased the
infarction size and brnin edema; d) transgenic ICAM-I-
deficient mice were less susceptible to bmin ische-
mia/reperfusion injury (39-45).
The time course ofthe expression of adhesion molecules
and proinflammatory cytokines was similar and parallel to the
time course of inflammatory cell infiltration in the ischemic
brain. suggesting that this coordinated molecular mechanism
was responsible for the innammaLOry response in cerebral
ischcmia (30, 46). The exact mechanisms by which ischemia
activated the expression of ICAM~I, YCAM-I and E-selectin
are still not clear. However, a possible mediator of this re-
sponse might have been thc nuclear factor kB (NF-kB) which
played an important role in regulating the cytokine-induced
transcription of endothelial adhesion molecules, and was acti-
vated by various factors induced by ischemia (47-49). Alter-
natively, the stimulation of adhesion molecule expression in
cerebral cndothclial cells by ischemia arisen from the
autocrine effects of IL-Ia. and platelet-activating factor, since
both were shown to stimulate leukocyte adhesion and were
secreted by peripheral endothelial cells exposed to ischemia
(48,50).
These secondary changes (inflammation) might have po-
tentiated already existing neuronal damage, and also led to the
further damage spread on the preserved neurons. Because
there was a certain time latency between the formation of the
primary and the secondary damage, il was expectable lhat ex-
actly this data offered the possibility of therapy application
that impeded the fonnation and the spreading of secondary
damage. According to the mentioned, it was also expectable
that the relation (balance) between proinflammatory and im-
munoinductive (immunomodulatory) processes would deter-
mine the direction of physiopathological events in the acute
IBD phase.
According to the results obtained in this research, it can
be concluded that: total number of leukocytes in the periph-
eral blood, as well as the soluble adhesion molecules (sI-
CAM-I, sYCAM-I and sE-selectin) levels in plasma and
CSF, were increased during the acute ISD phase progres~
sively compared 10 the severeness of the disease. Thus it was
concluded that they might have been the indicators of the in-
flammatory eNS reaction intensity. Moreover, the results \n-
dicated their role in IBD pathogenesis and offered the possi-
bility of researching the application of antagonists and/or the
activity modulator of some of them (leukocytes, ICAM-!,
YCAM-I, E-selcctin) in IBD therapy.
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Apstrakt
Selakovic V, Colic M, Jovanovic M, Raicevic R, Jovicic A. Vojnosanlt Pregl
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KONCENTRACIJA SOLUBILNOG INTERCELULARNOG ADHEZIJSKOG
MOLEKULA 1, VASKULARNOG CELlJSKOG ADHEZIJSKOG MOLEKULA 1 I
ENDOTELNOG LEUKOCITNOG ADHEZIJSKOG MOLEKULA U
CEREBROSPINALNOJ TECNOSTI I PLAZMI BOLESNIKA SA AKUTNOM
ISHEMIJSKOM BOLESCU MOZGA
Uvod. Migracija leukocita u podrucje ishemije je slozen proces, kontrolisan
preko adhezijsklh molekula (AM) na leukocitima i endotelu, preko migratornog
kapaciteta leukocita i prisustva hemotaksijskih agenasa u tkivu. U ovom is-
Irazivanju pretposlavljeno je da u krvi i cerebrospinalnoj tecnosli (CST)
bolesnika sa ishemijskom bolescu mozga (IBM) u akulnoj fazi posloje znacaj-
ne promene u koncentraciji solubilnih AM (sICAM-1, sVCAM-1 i sE-selektina),
koje mogu bili pokazatelji inlenziteta ostecujucih procesa u centralnom nerv-
nom sistemu (CNS). Metode, Istrazivanjem je obuhvaceno 45 bolesnika sa
IBM, oba pola, prosecne starosti 66±? godina, od kojih je 15 imalo tranzitorniCTP3H3 146 BOJHOCAHHTETCKH nPErJIE.ll
ishemijski atak (TIA), 15 reverzibilni ishemijski atak (RIA) I 15 infarkt mozga
(1M). Kontrolna grupa obuhvatila je 15 ispitanika sa radiksnim lezijama diskus-
nog porekla, podvrgnutih dijagnostickoj radikulografiji, bez znakova smetnji u
prolasku CST. Kod svih bolesnika odabrani biohemijski parametari odredivani
su prvih 72 casa nakon nastanka epizode ishemije. Koncentracije solubilnih
AM u plazmi i CST odredivane su pomoeu ELISA. Ukupan broj leukocita (UBL)
u perifernoj krvi odredivan je pomoeu hematoloskog analizatora. Rezultati.
Rezultati su pokazali da tokom prvih 72 casa IBM dolazi do znacajnog porasta
UBL i to progresivno u odnosu na tezinu bolesti. Pokazan je i znacajan porast
koncentracije solubilnih AM u plazmi bolesnika sa IBM, s tim sto je porast naj-
veei kod bolesnika sa 1M, nesto nizi kod RIA i najnizi kod TIA u odnosu na kon-
trolu. U CST koncentracije sICAM-1, sVCAM-1 i sE-selektina pokazuju slican
porast kao u plazmi. Zakljucak. Moze se zakljuciti da su UBL, kao i koncen-
tracije solubilnih AM u plazmi i CST, poveeani tokom akutne faze IBM i to pro-
gresivno u odnosu na tezinu bolesti, tako da mogu biti pokazatelji intenziteta
inflamacijske reakcije CNS-a. Pored toga, rezultati ukazuju na ulogu solubilnih
AM u patogenezi IBM, sto otvara moguenost ispitivanja primene antagonista
i/ili modulatora aktivnosti nekih od njih u terapiji IBM.
Epoj 2
K Ij u c n ere c i : mozak, ishemija; krv; cerebrospinalna
tecnost; leukociti; adhezijski molekul-1,
intercelularni; adhezijski molekul-1, celijski,
vaskularni; E-selektin; zapaljenje.
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